As a whole, the more frequent use of TNF-a antagonists in recent years in patients with major organ involvement, also suggested by the recent EULAR recommendations, requires more research on the infectious side-effects of anti-TNFa treatments in BD (1). The gene discussed is TNF; the disease is Behcet disease.